LYTIX BIOPHARMA ASLYTIX BIOPHARMA ASLYTIX BIOPHARMA AS

LYTIX BIOPHARMA AS

No trades
See on Supercharts

LYTIX fundamentals

LYTIX BIOPHARMA AS financial statements, including revenue, expenses, profit, and loss

The total revenue of LYTIX for the last quarter is 0.00 NOK, and it's 100.00% lower compared to the previous quarter. The net income of Q2 24 is -21.43 M NOK.

Q4 '22
Q1 '23
Q2 '23
Q3 '23
Q4 '23
Q1 '24
Q2 '24
‪0.00‬
Total revenue
Gross profit
Operating income
Pretax income
Net income
Currency: NOK
Q4 '22
Q1 '23
Q2 '23
Q3 '23
Q4 '23
Q1 '24
Q2 '24
TTM
Total revenueYoY growth
Gross profitYoY growth
Pretax incomeYoY growth
Net incomeYoY growth
EBITDAYoY growth
EBITYoY growth